Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypogonadism | 28 | 2022 | 805 | 2.550 |
Why?
|
Testosterone | 29 | 2022 | 2493 | 1.760 |
Why?
|
Gonadotropin-Releasing Hormone | 22 | 2019 | 1149 | 1.410 |
Why?
|
Luteinizing Hormone | 18 | 2019 | 822 | 1.010 |
Why?
|
Follicle Stimulating Hormone | 12 | 2010 | 727 | 1.000 |
Why?
|
Turner Syndrome | 5 | 2021 | 130 | 0.720 |
Why?
|
Gonadotropins | 8 | 2010 | 241 | 0.680 |
Why?
|
Klinefelter Syndrome | 1 | 2019 | 48 | 0.650 |
Why?
|
Hormone Replacement Therapy | 7 | 2022 | 757 | 0.620 |
Why?
|
Neurosecretory Systems | 6 | 2019 | 223 | 0.590 |
Why?
|
Inhibins | 8 | 2013 | 210 | 0.520 |
Why?
|
Receptors, LHRH | 8 | 2009 | 158 | 0.500 |
Why?
|
Gonadal Steroid Hormones | 6 | 2010 | 708 | 0.490 |
Why?
|
Performance-Enhancing Substances | 1 | 2014 | 30 | 0.470 |
Why?
|
Androgens | 6 | 2019 | 1285 | 0.450 |
Why?
|
Hypothalamus | 4 | 2010 | 1004 | 0.410 |
Why?
|
Spermatogenesis | 2 | 2012 | 260 | 0.390 |
Why?
|
Estradiol | 8 | 2010 | 1952 | 0.380 |
Why?
|
Pituitary Gland | 3 | 2010 | 634 | 0.340 |
Why?
|
Polycystic Ovary Syndrome | 5 | 2015 | 383 | 0.340 |
Why?
|
Kallmann Syndrome | 10 | 2010 | 142 | 0.340 |
Why?
|
Hyperthyroidism | 1 | 2012 | 292 | 0.340 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2022 | 554 | 0.310 |
Why?
|
Iodine Radioisotopes | 1 | 2012 | 1034 | 0.300 |
Why?
|
DNA Nucleotidyltransferases | 2 | 1999 | 177 | 0.300 |
Why?
|
Insulin Resistance | 4 | 2019 | 3982 | 0.290 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 7 | 2009 | 260 | 0.260 |
Why?
|
Integrases | 2 | 1999 | 520 | 0.260 |
Why?
|
Leydig Cells | 1 | 2005 | 55 | 0.250 |
Why?
|
Menstrual Cycle | 2 | 2008 | 546 | 0.240 |
Why?
|
Hormone Antagonists | 3 | 2001 | 108 | 0.240 |
Why?
|
Reproduction | 3 | 2013 | 646 | 0.230 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2004 | 33 | 0.230 |
Why?
|
Aromatase Inhibitors | 3 | 2007 | 519 | 0.220 |
Why?
|
Oxidative Phosphorylation | 1 | 2005 | 501 | 0.210 |
Why?
|
Human Growth Hormone | 2 | 1999 | 651 | 0.210 |
Why?
|
Testis | 6 | 2013 | 784 | 0.200 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2007 | 628 | 0.200 |
Why?
|
Eunuchism | 1 | 2001 | 19 | 0.190 |
Why?
|
Karyotyping | 2 | 2021 | 1177 | 0.180 |
Why?
|
Glucose | 1 | 2013 | 4352 | 0.180 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 34 | 0.180 |
Why?
|
Dipeptides | 2 | 2000 | 386 | 0.170 |
Why?
|
Ketoconazole | 3 | 2007 | 97 | 0.170 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1999 | 95 | 0.160 |
Why?
|
Survivors | 1 | 2010 | 2383 | 0.160 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11230 | 0.160 |
Why?
|
DNA Topoisomerases, Type I | 1 | 1999 | 108 | 0.160 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1883 | 0.160 |
Why?
|
Eukaryotic Cells | 1 | 1999 | 192 | 0.150 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4423 | 0.150 |
Why?
|
Male | 53 | 2022 | 365203 | 0.150 |
Why?
|
Extracellular Matrix Proteins | 5 | 2012 | 835 | 0.150 |
Why?
|
Diabetes Complications | 2 | 1995 | 1320 | 0.140 |
Why?
|
Adult | 44 | 2022 | 223851 | 0.140 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1091 | 0.140 |
Why?
|
Virilism | 1 | 1997 | 28 | 0.140 |
Why?
|
Blood Chemical Analysis | 2 | 2018 | 436 | 0.140 |
Why?
|
Mosaicism | 1 | 2021 | 481 | 0.140 |
Why?
|
Homozygote | 2 | 2001 | 1780 | 0.140 |
Why?
|
Hypopituitarism | 1 | 1999 | 253 | 0.140 |
Why?
|
Humans | 75 | 2022 | 768970 | 0.140 |
Why?
|
Growth Hormone | 1 | 1999 | 573 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12253 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2004 | 1408 | 0.130 |
Why?
|
Fertility | 1 | 2001 | 771 | 0.130 |
Why?
|
Periodicity | 1 | 1998 | 348 | 0.130 |
Why?
|
Genes, BRCA1 | 1 | 2000 | 756 | 0.130 |
Why?
|
Ovarian Cysts | 1 | 1997 | 108 | 0.130 |
Why?
|
Mutagenesis | 1 | 2000 | 1229 | 0.130 |
Why?
|
Goiter | 1 | 1996 | 86 | 0.130 |
Why?
|
Thyrotoxicosis | 1 | 1996 | 85 | 0.120 |
Why?
|
Renin-Angiotensin System | 2 | 1997 | 736 | 0.120 |
Why?
|
Valproic Acid | 2 | 2008 | 444 | 0.120 |
Why?
|
Pituitary Diseases | 1 | 1996 | 137 | 0.120 |
Why?
|
Cystic Fibrosis | 2 | 1995 | 1295 | 0.120 |
Why?
|
Migraine Disorders | 1 | 2008 | 1713 | 0.120 |
Why?
|
Aldosterone | 2 | 1997 | 881 | 0.120 |
Why?
|
Pedigree | 11 | 2010 | 4545 | 0.120 |
Why?
|
Insulin | 2 | 2010 | 6610 | 0.120 |
Why?
|
Mutagenesis, Insertional | 1 | 1997 | 662 | 0.120 |
Why?
|
Orchiectomy | 2 | 2010 | 468 | 0.110 |
Why?
|
Phenotype | 11 | 2021 | 16731 | 0.110 |
Why?
|
Oligopeptides | 2 | 2010 | 1194 | 0.110 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1750 | 0.110 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2013 | 25 | 0.110 |
Why?
|
Blood Glucose | 3 | 2010 | 6435 | 0.110 |
Why?
|
Abdominal Muscles | 1 | 1994 | 172 | 0.110 |
Why?
|
Estrogens | 1 | 2000 | 1536 | 0.110 |
Why?
|
Oxygen | 1 | 2005 | 4272 | 0.110 |
Why?
|
Hyperprolactinemia | 2 | 2008 | 124 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2000 | 1156 | 0.110 |
Why?
|
Mutation | 15 | 2012 | 30266 | 0.110 |
Why?
|
Puberty, Delayed | 4 | 2009 | 124 | 0.110 |
Why?
|
Epilepsy | 2 | 2008 | 3326 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2001 | 3726 | 0.110 |
Why?
|
Renal Dialysis | 1 | 2022 | 1789 | 0.110 |
Why?
|
Feedback | 3 | 2001 | 799 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1209 | 0.100 |
Why?
|
Edema | 1 | 1997 | 766 | 0.100 |
Why?
|
Postmenopause | 2 | 2003 | 2519 | 0.100 |
Why?
|
Ovary | 1 | 1997 | 965 | 0.100 |
Why?
|
Endocrinology | 1 | 2018 | 443 | 0.100 |
Why?
|
Mitochondria | 1 | 2005 | 3682 | 0.100 |
Why?
|
Body Composition | 4 | 2010 | 2462 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2008 | 1248 | 0.090 |
Why?
|
Prevalence | 3 | 2019 | 15879 | 0.090 |
Why?
|
Liver Diseases | 1 | 2019 | 1305 | 0.090 |
Why?
|
Odds Ratio | 2 | 2022 | 9684 | 0.090 |
Why?
|
Genetic Counseling | 1 | 2015 | 634 | 0.090 |
Why?
|
Molecular Sequence Data | 8 | 2007 | 17629 | 0.090 |
Why?
|
Diabetic Neuropathies | 1 | 1994 | 410 | 0.090 |
Why?
|
Sexual Maturation | 1 | 2012 | 258 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5131 | 0.090 |
Why?
|
Infertility, Male | 1 | 2013 | 398 | 0.090 |
Why?
|
Seminiferous Tubules | 1 | 2009 | 25 | 0.090 |
Why?
|
Puberty | 3 | 2009 | 501 | 0.090 |
Why?
|
Mutation, Missense | 3 | 2019 | 2592 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2010 | 702 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 764 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 1999 | 3840 | 0.080 |
Why?
|
Aging | 3 | 2018 | 8745 | 0.080 |
Why?
|
Feedback, Physiological | 2 | 2008 | 481 | 0.080 |
Why?
|
Seminiferous Epithelium | 1 | 2008 | 9 | 0.080 |
Why?
|
Recombinases | 2 | 1999 | 70 | 0.080 |
Why?
|
Lymphocytes | 1 | 1996 | 2614 | 0.080 |
Why?
|
Hyperandrogenism | 1 | 2008 | 46 | 0.080 |
Why?
|
Conserved Sequence | 3 | 2007 | 1162 | 0.070 |
Why?
|
Middle Aged | 21 | 2022 | 223737 | 0.070 |
Why?
|
Gastrointestinal Hormones | 1 | 2008 | 101 | 0.070 |
Why?
|
Population Surveillance | 1 | 2018 | 2597 | 0.070 |
Why?
|
Ovulation | 1 | 2008 | 181 | 0.070 |
Why?
|
Amino Acid Sequence | 6 | 2007 | 13427 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3591 | 0.070 |
Why?
|
Olfaction Disorders | 3 | 2006 | 225 | 0.070 |
Why?
|
Nerve Tissue Proteins | 5 | 2012 | 4413 | 0.070 |
Why?
|
Reference Values | 5 | 2015 | 4940 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2007 | 354 | 0.070 |
Why?
|
Athletes | 1 | 2014 | 1162 | 0.070 |
Why?
|
Receptors, Peptide | 1 | 2008 | 280 | 0.070 |
Why?
|
Triazines | 1 | 2008 | 311 | 0.070 |
Why?
|
Aged | 15 | 2022 | 171786 | 0.060 |
Why?
|
Young Adult | 8 | 2022 | 60131 | 0.060 |
Why?
|
Partial Pressure | 1 | 2005 | 248 | 0.060 |
Why?
|
Remission, Spontaneous | 2 | 2007 | 385 | 0.060 |
Why?
|
Adipokines | 1 | 2007 | 309 | 0.060 |
Why?
|
Nitriles | 2 | 2001 | 990 | 0.060 |
Why?
|
Triazoles | 2 | 2001 | 904 | 0.060 |
Why?
|
Glucocorticoids | 3 | 2006 | 2167 | 0.060 |
Why?
|
Glucose Clamp Technique | 1 | 2005 | 263 | 0.060 |
Why?
|
Administration, Oral | 1 | 2013 | 4040 | 0.060 |
Why?
|
Carcinoma | 1 | 1996 | 2340 | 0.060 |
Why?
|
Sperm Count | 3 | 2013 | 229 | 0.060 |
Why?
|
Amenorrhea | 1 | 2008 | 484 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2004 | 196 | 0.060 |
Why?
|
Adolescent | 14 | 2019 | 89244 | 0.060 |
Why?
|
Immunoassay | 1 | 2007 | 746 | 0.060 |
Why?
|
Recombination, Genetic | 2 | 1999 | 1526 | 0.060 |
Why?
|
Waist-Hip Ratio | 1 | 2005 | 520 | 0.050 |
Why?
|
Female | 30 | 2021 | 397515 | 0.050 |
Why?
|
Plasmids | 2 | 2000 | 2269 | 0.050 |
Why?
|
Radiotherapy | 1 | 2010 | 1506 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2004 | 11521 | 0.050 |
Why?
|
Neuropeptides | 1 | 2008 | 951 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 1996 | 2360 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 1996 | 2974 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2005 | 402 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2680 | 0.050 |
Why?
|
Glucose Intolerance | 1 | 2005 | 579 | 0.050 |
Why?
|
Gonadotropins, Pituitary | 1 | 2000 | 70 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2001 | 150 | 0.040 |
Why?
|
Bromocriptine | 1 | 2000 | 93 | 0.040 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 3 | 2009 | 29 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2010 | 10765 | 0.040 |
Why?
|
Giant Cell Arteritis | 1 | 2004 | 307 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1567 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39394 | 0.040 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 458 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 2000 | 575 | 0.040 |
Why?
|
Time Factors | 5 | 2012 | 40261 | 0.040 |
Why?
|
Secretory Rate | 1 | 1998 | 82 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6991 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2022 | 997 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1596 | 0.040 |
Why?
|
Base Sequence | 4 | 2007 | 12430 | 0.040 |
Why?
|
Repressor Proteins | 2 | 2000 | 2986 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2019 | 164 | 0.040 |
Why?
|
Genotype | 6 | 2009 | 13048 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2000 | 716 | 0.040 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2018 | 43 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4712 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 526 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 1999 | 320 | 0.040 |
Why?
|
Body Water | 1 | 1999 | 340 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2008 | 1924 | 0.040 |
Why?
|
Body Mass Index | 2 | 2022 | 13055 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1629 | 0.040 |
Why?
|
Binding Sites | 2 | 2004 | 6023 | 0.040 |
Why?
|
Bone and Bones | 1 | 2008 | 2590 | 0.030 |
Why?
|
Androstenedione | 1 | 1997 | 132 | 0.030 |
Why?
|
Models, Molecular | 3 | 2007 | 5404 | 0.030 |
Why?
|
Ligands | 1 | 2004 | 3283 | 0.030 |
Why?
|
Catalytic Domain | 1 | 1999 | 699 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1683 | 0.030 |
Why?
|
Leptin | 1 | 2005 | 1597 | 0.030 |
Why?
|
Nifedipine | 1 | 1997 | 220 | 0.030 |
Why?
|
Prospective Studies | 4 | 2008 | 54962 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2013 | 6512 | 0.030 |
Why?
|
Protein Conformation | 2 | 2006 | 3956 | 0.030 |
Why?
|
Evidence-Based Medicine | 3 | 2018 | 3709 | 0.030 |
Why?
|
Catalysis | 1 | 1997 | 768 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1629 | 0.030 |
Why?
|
Salmonella typhimurium | 1 | 1997 | 347 | 0.030 |
Why?
|
Dogs | 1 | 2000 | 3845 | 0.030 |
Why?
|
Models, Genetic | 2 | 2007 | 3449 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2010 | 365 | 0.030 |
Why?
|
Immunoblotting | 1 | 1997 | 1647 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2008 | 3081 | 0.030 |
Why?
|
Gene Frequency | 3 | 2008 | 3626 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2202 | 0.030 |
Why?
|
COS Cells | 2 | 2009 | 1135 | 0.030 |
Why?
|
Pulse Therapy, Drug | 1 | 2013 | 37 | 0.030 |
Why?
|
Heterozygote | 3 | 2007 | 2798 | 0.030 |
Why?
|
Hyperplasia | 1 | 1997 | 1154 | 0.030 |
Why?
|
Osteoporosis | 1 | 2003 | 1606 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3775 | 0.030 |
Why?
|
Dexamethasone | 1 | 2001 | 1965 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2010 | 4978 | 0.030 |
Why?
|
Drug Resistance | 1 | 1999 | 1599 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4785 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2003 | 2649 | 0.030 |
Why?
|
Blotting, Western | 1 | 2000 | 5033 | 0.030 |
Why?
|
Alopecia | 1 | 1997 | 416 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1997 | 990 | 0.030 |
Why?
|
Gene Deletion | 1 | 2000 | 2674 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7453 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3057 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 1996 | 842 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 74976 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2012 | 65480 | 0.020 |
Why?
|
Prognosis | 1 | 2012 | 30046 | 0.020 |
Why?
|
Animals | 8 | 2009 | 169335 | 0.020 |
Why?
|
Fetus | 1 | 1998 | 1882 | 0.020 |
Why?
|
Fatal Outcome | 1 | 1996 | 1836 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1999 | 1943 | 0.020 |
Why?
|
DNA | 3 | 2010 | 7214 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6086 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1996 | 793 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 1996 | 1137 | 0.020 |
Why?
|
Azoospermia | 1 | 2010 | 28 | 0.020 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2015 | 504 | 0.020 |
Why?
|
Transcription Factors | 4 | 2019 | 12174 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 2 | 2000 | 229 | 0.020 |
Why?
|
Aequorin | 1 | 2008 | 15 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2008 | 4124 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 2009 | 458 | 0.020 |
Why?
|
Anovulation | 1 | 2008 | 54 | 0.020 |
Why?
|
Child | 4 | 2019 | 80960 | 0.020 |
Why?
|
Protein Binding | 2 | 1997 | 9344 | 0.020 |
Why?
|
Body Weight | 1 | 1999 | 4628 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3214 | 0.020 |
Why?
|
Estriol | 1 | 2007 | 53 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1996 | 2916 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2019 | 81903 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2009 | 594 | 0.020 |
Why?
|
Bone Density | 1 | 2000 | 3574 | 0.020 |
Why?
|
Cohort Studies | 5 | 2009 | 41808 | 0.020 |
Why?
|
Fibroblast Growth Factor 8 | 1 | 2007 | 62 | 0.020 |
Why?
|
Adipose Tissue | 1 | 1999 | 3335 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2408 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9618 | 0.020 |
Why?
|
Estrone | 1 | 2007 | 234 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2010 | 404 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 1998 | 13021 | 0.020 |
Why?
|
Cricetulus | 1 | 2008 | 812 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 42683 | 0.020 |
Why?
|
Pregnancy | 3 | 2015 | 30265 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1313 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3968 | 0.020 |
Why?
|
CHO Cells | 1 | 2008 | 1379 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19023 | 0.020 |
Why?
|
Sex Factors | 1 | 1999 | 10633 | 0.010 |
Why?
|
Mental Health | 1 | 2019 | 3275 | 0.010 |
Why?
|
Intra-Abdominal Fat | 1 | 2010 | 625 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2008 | 737 | 0.010 |
Why?
|
Methods | 1 | 2005 | 1066 | 0.010 |
Why?
|
Cricetinae | 1 | 2008 | 2423 | 0.010 |
Why?
|
Inheritance Patterns | 1 | 2006 | 344 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2268 | 0.010 |
Why?
|
Escherichia coli | 1 | 1996 | 4213 | 0.010 |
Why?
|
Rats | 1 | 2000 | 23786 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3274 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2003 | 6569 | 0.010 |
Why?
|
Menstruation | 1 | 2005 | 310 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3346 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4592 | 0.010 |
Why?
|
Internationality | 1 | 2008 | 1008 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2749 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1498 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1798 | 0.010 |
Why?
|
Cryptorchidism | 1 | 2002 | 153 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1742 | 0.010 |
Why?
|
Testicular Hormones | 1 | 2002 | 188 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1794 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 2004 | 555 | 0.010 |
Why?
|
Genetic Variation | 2 | 2006 | 6611 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 22389 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2002 | 375 | 0.010 |
Why?
|
Polymorphism, Genetic | 2 | 2001 | 4251 | 0.010 |
Why?
|
Reference Standards | 1 | 2004 | 1014 | 0.010 |
Why?
|
Cleft Palate | 1 | 2006 | 597 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5763 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8513 | 0.010 |
Why?
|
Proprotein Convertases | 1 | 2000 | 95 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 1255 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1994 | 3447 | 0.010 |
Why?
|
Mass Screening | 1 | 1995 | 5457 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 2002 | 420 | 0.010 |
Why?
|
Smell | 1 | 2001 | 261 | 0.010 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2000 | 308 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2001 | 625 | 0.010 |
Why?
|
Operator Regions, Genetic | 1 | 1996 | 33 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2000 | 20776 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3813 | 0.010 |
Why?
|
DNA Footprinting | 1 | 1996 | 97 | 0.010 |
Why?
|
Hypertension | 1 | 1997 | 8617 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1995 | 5892 | 0.010 |
Why?
|
Operon | 1 | 1996 | 371 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2000 | 1159 | 0.010 |
Why?
|
X Chromosome | 1 | 1998 | 819 | 0.010 |
Why?
|
Renin | 1 | 1997 | 648 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4862 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6805 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1998 | 2342 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1997 | 969 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13674 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10400 | 0.010 |
Why?
|
Mice | 1 | 2000 | 82072 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59739 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14752 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9499 | 0.010 |
Why?
|
HIV Infections | 2 | 2010 | 17591 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1996 | 2003 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8559 | 0.000 |
Why?
|
Research Design | 1 | 2004 | 6214 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9519 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5801 | 0.000 |
Why?
|
Blood Pressure | 1 | 1997 | 8544 | 0.000 |
Why?
|
United States | 1 | 2008 | 73186 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 36854 | 0.000 |
Why?
|